FeesSafety
Pluang+

Oramed shifts focus to investments, sees gains but faces cash and dilution risks

Market News
11 Sep 2026, 22:53 WIB
Seeking Alpha
View Source
Neutral
Oramed shifts focus to investments, sees gains but faces cash and dilution risks

Oramed Pharmaceuticals is shifting from drug development to strategic investments, showing strong returns from stakes in Lifeward, Scilex, and Alpha Tau Medical. Alpha Tau's product has regulatory approvals and a lucrative U.S. deal but carries clinical risks. Oramed's cash is limited to $15.24M with a 12-month runway, raising concerns about potential dilution if new deals or asset sales don't occur. Investors should watch the company's ability to manage cash and capitalize on its diversified portfolio moving forward.

More News

Rakuten Kobo's 2026 report reveals niche reading trends, from sports romances to classic revivals and screen adaptations.

Rakuten Kobo's 2026 report reveals niche reading trends, from sports romances to classic revivals and screen adaptations.

Rakuten Kobo's 2026 annual report highlights a shift in global reading habits towards niche communities and diverse genres like sports romances, dark romance, and cozy mysteries. The report notes the fragmentation of traditional bestseller lists as r...

Others
Neutral
36 minutes ago
Anthropic sets aside up to 20% of its IPO shares for retail investors, doubling usual allocation.

Anthropic sets aside up to 20% of its IPO shares for retail investors, doubling usual allocation.

Anthropic, an AI company, is reserving up to 20% of its initial public offering (IPO) shares specifically for retail investors. This allocation is significantly higher than the typical 5% to 10% usually offered to individual investors in IPOs. By doi...

Others
Bullish
1 hour ago
DataParser enables firms to archive Zoom AI meeting summaries for compliance and oversight.

DataParser enables firms to archive Zoom AI meeting summaries for compliance and oversight.

DataParser by 17a-4 LLC now supports capturing Zoom AI meeting summaries along with transcripts and recordings for regulatory compliance. This solution helps firms retain, supervise, and search AI-generated content, closing gaps in archiving platform...

Others
Bullish
1 hour ago
ZPMC signs RMB 2.835B import contracts at CIIE, total procurement now exceeds RMB 20B.

ZPMC signs RMB 2.835B import contracts at CIIE, total procurement now exceeds RMB 20B.

At the 9th China International Import Expo (CIIE), Shanghai Zhenhua Heavy Industries (ZPMC) signed import procurement contracts worth RMB 2.835 billion with 12 overseas suppliers including Siemens and ABB. This brings ZPMC's cumulative procurement co...

Market News
Bullish
1 hour ago
Devia launches AI platform to streamline pharma quality deviation investigations globally

Devia launches AI platform to streamline pharma quality deviation investigations globally

Devia, an AI platform spun out from Visium, has launched to help biopharma companies, CDMOs, and CROs manage GxP quality deviations more efficiently. It automates the entire deviation lifecycle from reporting to root cause analysis and CAPA, reducing...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App